Multimedia
View More
On-demand CCO Webcast on emerging and established HER2-targeted therapies for HER2-positive early and metastatic breast cancer
Neelima Denduluri, MD, FASCO
Lee Schwartzberg, MD, FACP
Physicians:
maximum of 1.25 AMA PRA Category 1 Credits™
Released: August 11, 2020
Expired: August 10, 2021
On-demand CCO Webcast featuring Drs. Sara Hurvitz and Sara Tolaney on leveraging new and established treatments for HR+/HER2- advanced breast cancer
Sara Hurvitz, MD, FACP
Sara Tolaney, MD, MPH
Physicians:
maximum of 1.25 AMA PRA Category 1 Credits™
Released: August 11, 2020
Expired: August 10, 2021
Current treatment of HER2-positive early breast cancer, including neoadjuvant and adjuvant therapy from Clinical Care Options (CCO)
Lee Schwartzberg, MD, FACP
Physicians:
maximum of 1.0 AMA PRA Category 1 Credit™
Registered Nurses:
1.0 Nursing contact hour
Pharmacists:
1.0 contact hour (0.1 CEUs)
Released: August 10, 2020
Expired: August 9, 2021
In this slideset from Clinical Care Options (CCO), experts provide insights on the optimal use of checkpoint inhibitors for gastroesophageal cancers
Manish A. Shah, MD
Zev A. Wainberg, MD
Released: August 10, 2020
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.